-10%
New
Save 10%

Infla Support

€28.80

€32.00

Advanced formula for inflammation and pain control.
Synergistic formula with palmitoylethanolamide (OptiPEA®), turmeric (RHIZOmin 95®) and boswellia (AKBAzyme®) (30% AKBA).
Optimized with Pipermax® and AstraGin® for enhanced absorption and bioavailability.
Safe and natural alternative to traditional anti-inflammatory drugs.
100% natural ingredients.
Suitable for people with celiac disease.
Vegetable capsules suitable for vegan diets and free from titanium dioxide.

Size

60 VegeCaps

Quantity

En Stock

In today's Western society, the increase in chronic inflammation, insulin resistance, and sedentary lifestyle have increased the incidence of inflammatory diseases, musculoskeletal pain, and the abuse of anti-inflammatory drugs. To provide an effective and safe solution, Infla Support, from Vitobest®, it combines scientifically backed natural ingredients to modulate the inflammatory response and pain without the adverse effects of conventional drugs.

Its formula incorporates three active ingredients with synergistic action in controlling inflammation and pain: OptiPEA® (palmitoylethanolamide), RHIZOmin 95® (turmeric root extract) and AKBAzyme® (extract of resin from Boswellia serrata), which together with Pipermax® and AstraGin®, improve their absorption and bioavailability, enhancing their effect.

Infla Support: the natural ally against inflammation and pain.

OptiPEA®: It modulates the endocannabinoid system and activates PPAR-α receptors, reducing pro-inflammatory cytokines.^1,2.
RHIZOmin 95®: 95% standardized extract of curcuminoids, blocks NF-κB, COX-2 and LOX, reducing prostaglandins.^3.5.
AKBAzyme® (30% AKBA): Powerful 5-LOX inhibitor, prevents cartilage degradation and protects the intestinal barrier.⁶.

Pipermax® and AstraGin®: optimization of bioavailability^4.7.

Infla Support incorporates Pipermax® and AstraGin®, two patented ingredients that enhance the bioavailability of the actives.
Pipermax® It is a patented extract of 95% piperine, which improves the absorption of turmeric by up to 2000% and enhances the bioavailability of other ingredients.
AstraGin® it is a patented extract of Panax notoginseng and Astragalus membranaceus, designed to enhance nutrient absorption in the intestine and strengthen the intestinal barrier.

Recommended for:

People with chronic inflammation and joint diseases.
Athletes seeking muscle recovery and joint protection.
Pictures of intestinal dysbiosis or inflammatory digestive disorders.
Patients with autoimmune diseases or migraines of inflammatory origin.

Vitobest® use for this supplement vegetable capsules (VegeCaps) suitable for vegan diets and free of titanium dioxide.

Bibliography:

¹Gabrielsson L, Mattsson S, Fowler CJ. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol. 2016;82(4):932-942.

²Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH. Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Physician. 2017;20(5):353-362.

³Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59.

⁴Ammon HP. Boswellic acids and their role in chronic inflammatory diseases. Adv Exp Med Biol. 2016;928:291-327.

⁵"Jurenka JS." (Note: This is a proper name and remains the same in all languages.). Anti-inflammatory properties of curcumin, a major component of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141-153.

⁶Syrovets T, Büchele B, Krauss C, et al. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes through direct interaction with IκB kinases. J Immunol. 2005;174(1):498-506.

⁷EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of a botanical extract derived from Panax notoginseng and Astragalus membranaceus (AstraGin™) as a novel food according to Regulation (EU) 2015/2283. EFSA Journal. 2019;17(6):6099.

Reference V5883

In stock 176 Items

Specific References

ean13: 8436594158834

Allergens: none. Gluten-free.

Ingredients: OptiPEA®: palmitoylethanolamide (PEA), RHIZOmin 95®: dry extract of turmeric rhizome (Curcuma longa), thickener (capsule): hydroxypropylmethylcellulose, anti-caking agent: talc, AKBAzyme®: dry extract of boswellia resin (Boswellia serrata), anti-caking agents: silicon dioxide, Piperimax®: dry extract of black pepper fruit (Piper nigrum), anti-caking agent: magnesium salts of fatty acids and AstraGin®: extract of Panax notoginseng and Astragalus membranaceous.

Composition

per 2 VegeCaps

OptiPEA®: Palmitoylethanolamide (PEA)	600 mg
RHIZOmin 95®: Dry extract of turmeric rhizome
(95 % curcuminoids) (Curcuma longa)	300 mg
of which curcumin	210 mg
AKBAzyme®: Dry extract of boswellia resin (Boswellia serrata)
30 % AKBA	125 mg
Piperimax®: Dry extract of black pepper fruit (Piper nigrum) 35:1
95 % piperine	5 mg
AstraGin®: extract of Panax notoginseng and Astragalus membranaceous	3 mg
Extracts analyzed by HPLC

Take 2 VegeCaps a day.

WARNING: The products displayed here are nutritional supplements as defined by European Directive 2002/46/EC on food supplements. Food supplements are not intended to replace a balanced and varied diet; they are solely presented to complement the intake of nutrients in a normal diet. The information described about the ingredients may not be related to the final effect or benefits they may provide. They do not treat, prevent, diagnose, or cure any disease, as these are attributes of medicines, according to European Directive 2004/27/EC of 31 March, issued by the Council and the European Parliament on medicinal products. These products should not be used as a substitute for a diet or medication and must be kept out of reach of children.
The information and advice provided on this website are for informational purposes only. It is the User’s responsibility to consult a qualified doctor or nutritionist before starting any diet, training, or supplementation programme. The website owner assumes no responsibility for any potential damages or harm resulting from the use of the information contained on this website, nor for any misuse of the products offered through it.

Infla Support

Bibliography:

1Gabrielsson L, Mattsson S, Fowler CJ. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol. 2016;82(4):932-942.

2Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH. Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Physician. 2017;20(5):353-362.

3Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59.

4Ammon HP. Boswellic acids and their role in chronic inflammatory diseases. Adv Exp Med Biol. 2016;928:291-327.

5"Jurenka JS." (Note: This is a proper name and remains the same in all languages.). Anti-inflammatory properties of curcumin, a major component of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141-153.

6Syrovets T, Büchele B, Krauss C, et al. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes through direct interaction with IκB kinases. J Immunol. 2005;174(1):498-506.

7EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of a botanical extract derived from Panax notoginseng and Astragalus membranaceus (AstraGin™) as a novel food according to Regulation (EU) 2015/2283. EFSA Journal. 2019;17(6):6099.

Specific References

Infla Support

Quality seals footer

¹Gabrielsson L, Mattsson S, Fowler CJ. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol. 2016;82(4):932-942.

²Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH. Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Physician. 2017;20(5):353-362.

³Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59.

⁴Ammon HP. Boswellic acids and their role in chronic inflammatory diseases. Adv Exp Med Biol. 2016;928:291-327.

⁵"Jurenka JS." (Note: This is a proper name and remains the same in all languages.). Anti-inflammatory properties of curcumin, a major component of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141-153.

⁶Syrovets T, Büchele B, Krauss C, et al. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes through direct interaction with IκB kinases. J Immunol. 2005;174(1):498-506.

⁷EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of a botanical extract derived from Panax notoginseng and Astragalus membranaceus (AstraGin™) as a novel food according to Regulation (EU) 2015/2283. EFSA Journal. 2019;17(6):6099.